Head-to-head comparison
Claya vs TeleCareSpot
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.
$299/mo sema · $299/mo tirz · Verified June 2026
Marked down on: States-served list not disclosed — you must check at checkout
Desk Score
TeleCareSpot is a telehealth weight-loss platform offering doctor-prescribed compounded GLP-1s with flat.
$299/mo (+ membership fee) sema · $399/mo tirz · Verified June 2026
Marked down on: The LegitScript seal ID this provider publishes, #45936855, does not resolve on LegitScript's own CDN — checked August 2026, alongside six seal IDs from other providers that returned normally in the same pass
TeleCareSpot takes this head-to-head with the higher Desk Score, 71/100 (C) against 68/100 (C) for Claya. Claya still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Claya
68/100
C
TeleCareSpot
71/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Claya | TeleCareSpot |
|---|---|---|
| Semaglutide | $299/mo$299/mo (compounded) | $299/mo+ membership fee$299/mo (all doses, plus a separate fee, compounded) |
| Tirzepatide | $299/mo$299/mo (compounded) | $399/mo$399/mo |
| Coverage | Not listed on Claya's site (checked June 2026) | 48 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | Compounded GLP-1 in injectable and oral-tablet forms with named clinicians. | Flat-priced compounded semaglutide or tirzepatide with broad state coverage. |
| Desk Score | 68/100C | 71/100C |
The verdict
Desk pick — TeleCareSpotTeleCareSpot takes this head-to-head with the higher Desk Score, 71/100 (C) against 68/100 (C) for Claya. Claya still holds its ground where its strengths line up with yours.
Choose Claya if…
Compounded GLP-1 in injectable and oral-tablet forms with named clinicians.
$299/mo sema · $299/mo tirz
Choose TeleCareSpot if…
Flat-priced compounded semaglutide or tirzepatide with broad state coverage.
$299/mo (+ membership fee) sema · $399/mo tirz · 48 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Claya · TeleCareSpot.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- Claya vs CoreAge Rx
- CoreAge Rx vs TeleCareSpot
- Apex MD vs Claya
- SkinnyRx vs TeleCareSpot
- Claya vs Kova
- Apex MD vs TeleCareSpot
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.